Dec 2023 $6 M No. 4 $2 to $10 million 1
Aditx Therapeutics, Inc.: Raise no. 4, Dec 2023 × Investors in this round 1 investor had bought by the notice of Jan 23, 2024: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold equity, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $495,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Amro Albanna · Executive Officer, Director · Chief Executive Officer Corinne Pankovcin · Executive Officer · Chief Commercialization Officer Rowena Albanna · Executive Officer · Chief Operating Officer Shahrokh Shabahang · Executive Officer, Director · Chief Innovation Officer Thomas Farley · Executive Officer · Chief Financial Officer Brian Brady · Director Charles Athle Nelson · Director Jeffrey Runge · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 375) · New York, New York Sold in CA Signed by Amro Albanna, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 23, 2024. Read the notice at the SEC .
equity SEC Sep 2023 $10 M No. 3 $10 to $50 million 1
Aditx Therapeutics, Inc.: Raise no. 3, Sep 2023 × Investors in this round 1 investor had bought by the notice of Sep 20, 2023: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $10 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $775,000
Finders' fees none
Paid to its own people $436,284 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Amro Albanna · Executive Officer, Director · Chief Executive Officer Corinne Pankovcin · Executive Officer · Chief Commercialization Officer Rowena Albanna · Executive Officer · Chief Operating Officer Shahrokh Shabahang · Executive Officer, Director · Chief Innovation Officer Thomas J. Farley · Executive Officer · Chief Financial Officer Brian J. Brady · Director Jeffrey W. Runge · Director Namvar J. Kiaie · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 375) · New York, New York Sold in NY Remarks in the notice On the use of proceeds: “Represents payment of voluntarily deferred payroll to executive officers.”Signed by Amro Albanna, Chief Executive Officer & Director. Source: SEC Form D, newest notice filed Sep 20, 2023. Read the notice at the SEC .
equity, options SEC Aug 2022 $2 M No. 2 $2 to $10 million 6
Aditx Therapeutics, Inc.: Raise no. 2, Aug 2022 × Investors in this round 6 investors had bought by the notice of Aug 17, 2022: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $70,700
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Amro Albanna · Executive Officer, Director Corinne Pankovcin · Executive Officer Matthew J. Shatzkes · Executive Officer Rowena Albanna · Executive Officer Shahrokh Shabahang · Executive Officer, Director Thomas J. Farley · Executive Officer Brian J. Brady · Director Jeffrey J. Runge · Director Namvar J. Kiaie · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Network 1 Financial Securities, Inc. (CRD 13577) · Red Bank, New Jersey Sold in all US states Crito Capital LLC (CRD 161724) · Westport, Connecticut Sold in all US states Signed by Amro Albanna, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 17, 2022. Read the notice at the SEC .
equity, debt, options SEC Jan 2021 $6 M No. 1 $2 to $10 million 1
Aditx Therapeutics, Inc.: Raise no. 1, Jan 2021 × Investors in this round 1 investor had bought by the notice of Jan 26, 2021: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Senior Secured Convertible Promissory Note Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $380,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Amro Albanna · Executive Officer, Director · Chief Executive Officer Corinne Pankovcin · Executive Officer · Chief Financial Officer and Secretary Rowena Albanna · Executive Officer · Chief Operating Officer Shahrokh Shabahang · Executive Officer, Director · Chief Innovation Officer Brian E. Brady · Director Jeffrey W. Runge · Director Laura E. Anthony · Director Namvar E. Kiaie · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Dawson James Securities, Inc. (CRD 130645) · Boca Raton, Florida Sold in all US states Signed by Amro Albanna, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 26, 2021. Read the notice at the SEC .
debt, options SEC